Analyst firms · Jefferies · VTRS
Jefferies VTRS price target and rating history
Viatris Inc. (VTRS) · Health Care
Jefferies rates Viatris Inc. (VTRS) Buy with a $15 price target, as of its latest action on Jul 19, 2024. It has published 3 rating actions on VTRS since October 2022, including 1 upgrade and 0 downgrades. Across 5 firms with a VTRS price target in the last 12 months, the median target is $18.
- Current rating
- Buy
- Price target
- $15
- Median target, all firms
- $18
- Actions on VTRS
- 3
Jefferies price target on VTRS
Every Jefferies rating on VTRS
- Jul 19, 2024
- Jan 27, 2023
- Oct 21, 2022
How other firms rate VTRS
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Oppenheimer | Outperform | $25 | Sep 23, 2026 |
| Leerink Partners | Outperform | $20 | Sep 9, 2026 |
| UBS | Buy | $18 | Feb 9, 2026 |
| Argus Research | Buy | $15 | Jan 16, 2026 |
| Barclays | Overweight | $15 | Dec 9, 2025 |
Questions about Jefferies and VTRS
- What is Jefferies's price target for VTRS?
- Jefferies's latest stated price target for Viatris Inc. (VTRS) is $15, from its action on Jul 19, 2024.
- What is Jefferies's rating on VTRS?
- Jefferies rates VTRS Buy, a bullish rating, as of Jul 19, 2024.
- When did Jefferies last change its view on VTRS?
- On Jul 19, 2024, Jefferies resumes coverage at Buy, price target $15.
- How does Jefferies's VTRS target compare with other analysts?
- Across 5 firms with a VTRS price target in the last 12 months, the median target is $18.
More VTRS rating histories
All Jefferies ratingsVTRS news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.